ArticleEuropean journal of nuclear medicine and molecular imaging2015

3'-Deoxy-3'-¹⁸F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer.

Amarnath Challapalli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.